David Jones Pty Ltd v Pharmaline Pty Ltd

Link copied
Case Copied 17 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by David Jones Pty Ltd to registration of trade mark application 1653738(35) and 1679107(44) - DAVID JONES PHARMACY - in the name of Pharmaline Pty Ltd

Delegate: Adrian Richards
Representation: Opponent: Edward Heerey of Counsel instructed by Georgina Hey and Rebecca Brenikov of Norton Rose Fullbright
Applicant: Andrew Fox of Counsel instructed by Alexandra Britt of Addisons
Decision: 2018 ATMO 60
Trade Marks Act 1995 (Cth) – opposition to registration under section 52 – ground of opposition under section 60 pressed and established – applications refused

Background

  1. This decision with reasons concerns the opposition to registration of two trade marks (together, ‘the Trade Marks’) in the name of Pharmaline Pty Ltd (‘the Applicant’), the relevant details of which are set out below:

    Application number:           1653738

    Trade mark:  DAVID JONES PHARMACY

    Specification of services:     Class 35: Pharmacy retail services

    Priority date:  22 October 2014

    Endorsement: Provisions of subsection s44(4) and/or Reg 4.15A(5) applied

    (‘the Pharmacy Mark’)

    Application number:           1679107

    Trade Mark:  DAVID JONES PHARMACY

    Specification of services:     Class 44: Medical advice for individuals with disabilities; Medical advisory services; Medical assistance; Medical care services; Medical clinic services; Medical counselling; Medical health assessment services; Medical screening; Medical services

    Priority date:  5 March 2015

    Endorsement: Provisions of subsection s44(4) and/or Reg 4.15A(5) applied

    (‘the Medical Mark’)

  2. After they had passed examination, in mid-2016 the Trade Marks were advertised as having been accepted for possible registration. In response to those advertisements, David Jones Pty Ltd (‘the Opponent’) filed a notice of intention to oppose and a statement of grounds and particulars against each of the Trade Marks.

  3. In accordance with the statutory timetables for filing evidence, the Opponent filed evidence in support and the Applicant filed evidence in answer. The Opponent had the option to file evidence in reply but did not exercise it. After the period for filing evidence in reply ended, this office informed the parties that the oppositions were ready to be heard.

  4. On 23 August 2017 the Opponent requested an oral hearing on the substantive matters. The oppositions to registration of the Trade Marks were accordingly set down for concurrent hearing on 2 March 2018.

  5. I was allocated to conduct the hearing and decide the oppositions in my capacity as a delegate of the Registrar of Trade Marks. In preparation for the upcoming hearing, I wrote to the parties on 31 January 2018. This email primarily sought to draw the parties’ attention to the statutory requirement that each file a written outline of submissions in the lead up to the hearing proper.

  6. The Opponent filed its outline of submissions precisely as was required. The Applicant, having had the advantage of reviewing the Opponent’s submissions before filing its own, took a different approach. When the time came for the Applicant’s outline of submissions to be filed, accompanying them was a pair of declarations. The more significant declaration was a copy of the evidence that the…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read David Jones Pty Ltd v Pharmaline Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2018] ATMO 60
Decision Date

CaseChat Overview and Summary

This decision concerns a dispute between David Jones Pty Ltd (the Applicant) and Pharmaline Pty Ltd (the Opponent) before the Australian Trade Marks Office. The core of the dispute revolves around the Opponent's opposition to the registration of certain trade marks by the Applicant. A significant procedural issue arose regarding the confidentiality of evidence, specifically statutory declarations, submitted by both parties.

The primary legal issues before the court were whether the Opponent's opposition to the Applicant's trade mark applications should succeed, and how to address the confidentiality claims made over the parties' evidence. The court was required to determine the extent to which it could refer to and rely upon the evidence presented, particularly in light of the statutory requirement to provide reasons for its decision that include findings on material questions of fact and the evidence upon which those findings are based.

The court acknowledged the difficulty in providing detailed reasons without referencing the evidence, which could contravene section 25D of the *Acts Interpretation Act 1901* (Cth). It noted that both parties had made broad claims of confidentiality over their statutory declarations. The court adopted an approach similar to previous decisions, stating that it would discuss commercially sensitive matters only to the extent necessary and that the parties' lack of specificity in their confidentiality claims had contributed to this challenge. The court then proceeded to discuss the evidence, including an overview of the Opponent's business and its use of the DAVID JONES trade marks, as well as the history of the Applicant's pharmacy business.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Both parties have included an ambit claim to confidentiality over the entirety of their respective statutory declarations. In fairness the Opponent’s position is more nuanced, since it also seeks to draw particular attention to the annexures it has clearly marked with ‘confidential’, as being confidential and commercially sensitive. Drafting these reasons without reference to any of the evidence would be challenging to put it mildly. Worse still, were that challenge met, the result would likely contravene s 25D of the Acts Interpretation Act 1901 (Cth):25 Content of statements of reasons for decisionsWhere an Act requires a tribunal, body or person making a decision to give written reasons for the decision, whether the expression "reasons", "grounds" or any other expression is used, the instrument giving the reasons shall also set out the findings on material questions of fact and refer to the evidence or other material on which those findings were based. So instead, with the exception of the Opponent’s confidential annexures, my approach to the discussion of evidence in these reasons proceeds along the same lines as earlier decisions from this office:It will be sufficient for me to say, in setting out my reasons for my decision, that there are arguably commercially sensitive matters in the evidence that I do not need to discuss in detail (and, if I do, my consolation lies in the fact that the [parties] in not being specific…[have] brought the problem upon [themselves]).[3][3] Source Homeloans Pty Ltd v Coles Group Ltd [2008] ATMO 17, [6]. With that in mind, I now turn to the content of the evidence. Hitchens provides an overview of the Opponent’s business in relation to its various DAVID JONES trade marks. Most relevant to the reasons that follow are the aspects of Hitchens that detail historical and contemporary use of the Opponent’s DAVID JONES trade marks, and their associated revenue figures, marketing and promotion. The detail of this evidence is better left for the discussion below ground of the opposition under s 60 of the Act. Le provides a history of the Applicant’s business that, due to the nature of s 60 of the Act, is of limited relevance to the discussion to follow. Despite that, these reasons would seem incomplete without some discussion of that history, since it provides the context in which registration of the Trade Marks has been sought. On 4 July 1916, a pharmacy business called ‘Perry’s Pharmacy’ opened its doors for the first time at the location of 448 Neerim Road, Murrumbeena, Victoria—a suburb 13 km south-east of the Melbourne central business district. In 1973, the pharmacy at that location had come to be owned by one David S. Jones, and so it was renamed ‘David Jones Pharmacy’. Under the ownership of Murray McLean, the name of the business was altered in 1995 to ‘David Jones Pharmacy (Murray McLean)’. When the Applicant took over the business from Mr McLean in 2013 it reverted to the name ‘David Jones Pharmacy’, and it continues to trade under this name.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.